Abstract:Objectives MicroRNAs, as one of key regulators for post-transcriptional gene control, have shown to be involved in cardiovascular diseases. This study aimed to investigate the roles of miR-378 in regulation of cardiac hypertrophy and cardiac fibrosis stimulated by pressure overload. Methods To construct cardiac remodelling mice models, pressure overload was imposed on the heart of C57B/L6 mice (8 weeks) by constriction of transverse aortic banding (TAC). Chemically modified oligonucleotides miRNA mimics (miR-378-Agomir) and inhibitors (miR-378-Antagomir) treatment started 24 h after TAC by intravenous injections on two consecutive days. Mice were randomly divided into four groups: 1) the TAC group; 2) the TAC-Agomir group; 3) the TAC- Antagomir group; 4) the Sham operation group. Mice after sham or 2 weeks TAC operation were subjected to hemodynamic and echocardiographic measurement. Tissue and serum miR-378 expressions were detected by TaqMan MicroRNA Assay Kit. ANP, BNP, β-MHC, collagen I and collagen III was measured by Real-time PCR. ERK1/2, p-ERK1/2, MMPs and α-SMA expression were analysed by western blotting. Collagen was assessed by immunohistochemistry. Results We found that miR-378 has a high expression pattern in the heart. After two-week acute pressure overload, the TAC group exhibit prominent cardiac hypertrophic responses and decreased expression of miR-378(p < 0.05) comparing with the sham group. In vivo overexpression of miR-378 in TAC-Agomir group markerly inhibited cardiac hypertrophy, accompanied with downregulation of fetal gene ANP, BNP and β-MHC compared to that of TAC group. Howerver, inhibition of endogenous miR-378 by an infusion of an antagomir caused sustained cardiac hypertrophy, associated with a reinduction of fetal gene expression to a less extent. The p-ERK level was also downregulated in TAC-Agomir group and upregulated in TAC- Antagomir group. In part of cardiac fibrosis, we found that the over-expression of miR-378 of TAC-Agomir group reduced the expression of col I, col III, MMP2, MMP9 and α-SMA(p < 0.05) compared to that of TAC group, whereas down regulation of endogenous miR-378 with anti-miRs promoted collagens and MMPs expression. Conclusions These findings reveal orchestrating regulatory roles for miR-378 in pressure-overload induced cardiac remodeling. It suggests that miR-378 not only suppresses cardiac hypertrophy by regulating fetal genes expression and ERK1/2 signaling pathway but also controls fibrosis-related genes expression in the heart.

Mir-421-mediated Suppression of FGF13 As a Novel Mechanism Ameliorates Cardiac Hypertrophy by Inhibiting Endoplasmic Reticulum Stress.

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Inhibition of Mir-146B-5p Alleviates Isoprenaline-Induced Cardiac Hypertrophy Via Regulating DFCP1.

Mir-145 Inhibits Isoproterenol-Induced Cardiomyocyte Hypertrophy by Targeting the Expression and Localization of GATA6

MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.

MicroRNA-34c-5p Provokes Isoprenaline-Induced Cardiac Hypertrophy by Modulating Autophagy Via Targeting ATG4B

Cardiac Fibroblast Mir‐27a May Function As an Endogenous Anti‐fibrotic by Negatively Regulating Early Growth Response Protein 3 (EGR3)

mir15a/mir16‐1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy

FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy

Crucial Role of Mir-433 in Regulating Cardiac Fibrosis.

Mir-218 Involvement in Cardiomyocyte Hypertrophy is Likely Through Targeting Rest

The mechanisms of microRNA-378 on suppressing cardiac fibrosis induced by hypertension

Microrna-214 Mediates Isoproterenol-Induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts

Fibroblast‐derived miR‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF‐β1/Smad signalling

MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling

Microrna-327 Regulates Cardiac Hypertrophy And Fibrosis Induced By Pressure Overload

GW24-e2270 MicroRNA-378 Plays Regulatory Roles in Pressure Overload-induced Cardiac Remodelling

Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice

Targeting Mir-30D Reverses Pathological Cardiac Hypertrophy

Mir-19B Controls Cardiac Fibroblast Proliferation and Migration.

Inhibition of Microrna-155 Ameliorates Cardiac Fibrosis in the Process of Angiotensin II-induced Cardiac Remodeling